Autoantibody repertoires to brain tissue in autism nuclear families

Journal of Neuroimmunology
Susana C SilvaAstrid M Vicente

Abstract

The hypothesis of an immune dysfunction in autism spectrum disorders has previously been put forward without, however, compelling evidence of a direct relation to its etiology or pathogenesis. To further understand if autoimmunity could play a significant role in autism, we analyzed autoantibody repertoires to brain tissue extract in the plasma of 171 autism children, their parents, and 54 controls, by quantitative immunoblotting. Multiparametric analysis revealed significant differences between patients and controls, and showed that one single reactivity in Section 32 of the blot had the most power to discriminate between these samples. Family correlation coefficients and heritability estimates did not provide any evidence that this reactivity was genetically determined. While the molecular weight of the target protein suggested that it might be an isoform of Myelin Basic Protein (MBP), inhibition assays with human MBP argued against this hypothesis. The study evidences the widespread occurrence of autoreactivities to brain tissue in autism patients, which may represent the immune system's neuroprotective response to a previous brain injury occurred during neurodevelopment. The molecular identification of the target protein in...Continue Reading

References

Jun 1, 1988·Journal of Autism and Developmental Disorders·A B Short, E Schopler
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T M PribylA T Campagnoni
Mar 1, 1993·Brain, Behavior, and Immunity·V K SinghP Cole
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·L MouthonM D Kazatchkine
Jan 1, 1994·Neuropsychobiology·A V PlioplysE Silverman
Dec 1, 1995·Current Opinion in Immunology·A CoutinhoS Avrameas
Mar 1, 1997·Journal of Child Psychology and Psychiatry, and Allied Disciplines·T van GentP D Treffers
Oct 3, 1998·Clinical Immunology and Immunopathology·V K SinghV C Yang
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·M HornigW I Lipkin
Jun 7, 2000·Molecular Medicine Today·M TurnerA Bailey
Jun 16, 2000·Journal of Immunological Methods·D StahlM D Kazatchkine
Dec 1, 2000·Journal of Autism and Developmental Disorders·S Gupta
Dec 1, 2000·Journal of Autism and Developmental Disorders·A W Zimmerman
Dec 6, 2001·Nature Reviews. Genetics·S E Folstein, B Rosen-Sheidley
Nov 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jonathan KipnisMichal Schwartz

❮ Previous
Next ❯

Citations

Sep 24, 2009·Cellular and Molecular Neurobiology·Salvatore A Currenti
Jun 21, 2007·Journal of Autism and Developmental Disorders·Nikki J KirkmanRobert S Fujinami
May 5, 2005·The Journal of Pediatrics·Simon Murch
Jul 21, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Milo CareagaPaul Ashwood
Sep 30, 2008·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Rodney R Dietert, Janice M Dietert
Nov 13, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yubin ZhangDavid A Lawrence
Jun 29, 2007·Journal of Translational Medicine·Thomas E IchimNeil H Riordan
Jul 13, 2006·Environmental Health Perspectives·Irva Hertz-PicciottoIsaac N Pessah
Apr 12, 2014·Molecular Autism·Catarina T CorreiaAstrid M Vicente
Apr 10, 2014·Biomarkers in Medicine·Nadra E Elamin, Laila Y Al-Ayadhi
Jan 13, 2006·International Review of Psychiatry·Carlos A PardoAndrew W Zimmerman
Sep 14, 2010·Brain, Behavior, and Immunity·Paul AshwoodJudy Van de Water
Sep 15, 2009·Pediatric Neurology·Christina M MorrisHarvey S Singer
Aug 12, 2009·Brain, Behavior, and Immunity·Amanda M EnstromPaul Ashwood
Jan 13, 2009·Brain, Behavior, and Immunity·Amanda EnstromPaul Ashwood
Sep 3, 2008·Brain, Behavior, and Immunity·Amanda M EnstromPaul Ashwood
Sep 7, 2007·Annals of the New York Academy of Sciences·Sharifia WillsJudy Van de Water
Sep 7, 2007·Annals of the New York Academy of Sciences·Maricel CabanlitJudy Van de Water
Aug 23, 2012·Developmental Neurobiology·Elizabeth FoxJudy Van de Water
Mar 5, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Catarina CorreiaAstrid M Vicente
Nov 18, 2004·Autoimmunity Reviews·Paul Ashwood, Judy Van de Water
Oct 13, 2006·Brain, Behavior, and Immunity·Andrew W ZimmermanDavid A Pearce
Jul 18, 2006·Journal of Neuroimmunology·Harvey S SingerAndrew W Zimmerman
Oct 4, 2005·Journal of Neuroimmunology·Boris SakicLaurie C Doering
Jul 21, 2015·Nature Reviews. Neuroscience·Myka L Estes, A Kimberley McAllister
Dec 21, 2007·Journal of Neuroimmunology·Harvey S SingerAndrew W Zimmerman
Dec 8, 2010·Brain, Behavior, and Immunity·Paula GoinesJudy Van de Water
Sep 13, 2011·Brain, Behavior, and Immunity·Charity OnorePaul Ashwood
Sep 10, 2011·Medical Hypotheses·Coad Thomas Dow
Apr 22, 2016·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ihsan CetinOmer Faruk Ozer
Nov 16, 2013·The International Journal of Neuropsychopharmacology·Jantine A C BroekSabine Bahn
Oct 29, 2005·Journal of Neuropathology and Experimental Neurology·Jane Pickett, Eric London
May 30, 2019·Psychopharmacology·Robyn P ThomChristopher J McDougle
Apr 9, 2020·Frontiers in Cellular and Infection Microbiology·Karuna E W VendrikMaria Fiorella Contarino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.